Diagnosis and management of peripheral arterial disease

G Peach, M Griffin, KG Jones, MM Thompson… - Bmj, 2012 - bmj.com
Peripheral arterial disease (PAD) is an atherosclerotic process that causes stenosis and
occlusion of non-cerebral and non-coronary arteries. It has an estimated worldwide …

Therapeutic angiogenesis for peripheral artery disease: lessons learned in translational science

SR Iyer, BH Annex - Basic to translational science, 2017 - jacc.org
Peripheral arterial disease (PAD) is a major health care problem. There have been limited
advances in medical therapies, and a huge burden of symptomatic patients with intermittent …

Type-2 pericytes participate in normal and tumoral angiogenesis

A Birbrair, T Zhang, ZM Wang… - … of Physiology-Cell …, 2014 - journals.physiology.org
Tissue growth and function depend on vascularization, and vascular insufficiency or excess
exacerbates many human diseases. Identification of the biological processes involved in …

[HTML][HTML] Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients …

AW Bradbury, DJ Adam, J Bell, JF Forbes… - Journal of vascular …, 2010 - Elsevier
BACKGROUND: A 2005 interim analysis of the Bypass versus Angioplasty in Severe
Ischaemia of the Leg (BASIL) trial showed that in patients with severe lower limb ischemia …

Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients

T Gary, M Pichler, K Belaj, F Hafner, A Gerger… - PloS one, 2013 - journals.plos.org
Background Platelet-to-Lymphocyte Ratio (PLR) is an easily applicable blood test. An
elevated PLR has been associated with poor prognosis in patients with different oncologic …

Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia

S Nikol, I Baumgartner, E Van Belle, C Diehm… - Molecular Therapy, 2008 - cell.com
This study evaluated the efficacy and safety of intramuscular administration of NV1FGF, a
plasmid-based angiogenic gene delivery system for local expression of fibroblast growth …

[PDF][PDF] Transcutaneous oximetry in clinical practice: consensus statements from an expert panel based on evidence.

CE Fife, DR Smart, PJ Sheffield, HW Hopf, G Hawkins… - practice, 2007 - researchgate.net
Fife CE, Smart DR, Sheffield PJ, Hopf HW, Hawkins G, Clarke D. Transcutaneous Oximetry
in Clinical Practice: Consensus statements from an expert panel based on evidence …

Thromboangiitis obliterans (Buerger's disease)—current practices

A Vijayakumar, R Tiwari… - International journal of …, 2013 - Wiley Online Library
Thromboangiitis obliterans (TAO) is a nonatherosclerotic, segmental inflammatory disease
that most commonly affects the small and medium‐sized arteries and veins in the upper and …

Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice

K Sarkar, K Fox-Talbot… - Proceedings of the …, 2009 - National Acad Sciences
Diabetes is a major risk factor for ischemic disease. Treatment options for diabetic patients
with peripheral arterial disease when revascularization is not possible are limited, resulting …

[HTML][HTML] Clinical implications of the angiosome model in peripheral vascular disease

BE Sumpio, RO Forsythe, KR Ziegler… - Journal of vascular …, 2013 - Elsevier
Vascular surgery has seen a revolutionary transformation in its approach to peripheral
vascular disease over the last 2 decades, fueled by technological innovation and a …